Approval · Notice of Compliance 227 · 2002
APTHERA: Notice of Compliance 227
Issued February 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 227
- Date
- February 4, 2002
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antihistaminic, anti-inflammatory, leukotriene inhibitor agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APTHERA | 02243118 | Cancelled Pre Market |
Medicinal ingredients
- AMLEXANOX 5 PER